203 related articles for article (PubMed ID: 35711568)
21. Signal peptidase complex catalytic subunit SEC11A upregulation is a biomarker of poor prognosis in patients with head and neck squamous cell carcinoma.
Hu C; Fan J; He G; Dong C; Zhou S; Zheng Y
PLoS One; 2022; 17(6):e0269166. PubMed ID: 35653344
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of HOX genes promotes cell migration and proliferation in head and neck squamous cell carcinoma.
Aguiar GM; Ramão A; Plaça JR; Simões SC; Scaraboto NV; Freitas-Castro F; Cardoso C; Sousa JF; Silva WA
Tumour Biol; 2021; 43(1):263-278. PubMed ID: 34633333
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of the prognosis and biological significance of ROR
Zheng J; Tang H; Yang Y; Yang K
Environ Toxicol; 2024 Feb; 39(2):487-508. PubMed ID: 37278231
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
25. Clinical powers of Aminoacyl tRNA Synthetase Complex Interacting Multifunctional Protein 1 (AIMP1) for head-neck squamous cell carcinoma.
Li Y; Liu H
Cancer Biomark; 2022; 34(3):359-374. PubMed ID: 35068446
[TBL] [Abstract][Full Text] [Related]
26. [Effect of
Yao YF; Liu W; Zhou ML; Qiu TL; Wang K
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 May; 53(3):457-465. PubMed ID: 35642155
[TBL] [Abstract][Full Text] [Related]
27. CCND1-associated ceRNA network reveal the critical pathway of TPRG1-AS1-hsa-miR-363-3p-MYO1B as a prognostic marker for head and neck squamous cell carcinoma.
Li Z; Qiu X; He Q; Fu X; Ji F; Tian X
Sci Rep; 2023 Jul; 13(1):11831. PubMed ID: 37481637
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptors signature reveal the head and neck squamous cell carcinoma energy metabolism phenotype and clinical outcome.
Yao Y; Wang D; Zhang Y; Tang Q; Xu Z; Qin L; Qu Y; Yan Z
J Gene Med; 2024 Jan; 26(1):e3605. PubMed ID: 37932968
[TBL] [Abstract][Full Text] [Related]
29. PI3K pathway mutation predicts an activated immune microenvironment and better immunotherapeutic efficacy in head and neck squamous cell carcinoma.
Wang L; Chen K; Weng S; Xu H; Ren Y; Cheng Q; Luo P; Zhang J; Liu Z; Han X
World J Surg Oncol; 2023 Mar; 21(1):72. PubMed ID: 36864522
[TBL] [Abstract][Full Text] [Related]
30. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
[TBL] [Abstract][Full Text] [Related]
31. Natural killer cell-based signature: Prognostic analysis in head and neck squamous cell carcinoma.
Guo Z; Zhao Y; Xu M; Zhao L; Wang X
J Gene Med; 2024 Feb; 26(2):e3671. PubMed ID: 38384136
[TBL] [Abstract][Full Text] [Related]
32. FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma.
Wu Q; Shao T; Huang G; Zheng Z; Jiang Y; Zeng W; Lv X
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291667
[No Abstract] [Full Text] [Related]
33.
Dai Y; Chen W; Huang J; Cui T
Biomed Res Int; 2021; 2021():8874578. PubMed ID: 34285919
[TBL] [Abstract][Full Text] [Related]
34. A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma.
Shi C; Liu S; Tian X; Wang X; Gao P
BMC Cancer; 2021 Sep; 21(1):1035. PubMed ID: 34530752
[TBL] [Abstract][Full Text] [Related]
35. Profiles of immune cell infiltration in head and neck squamous carcinoma.
Liang B; Tao Y; Wang T
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32095823
[TBL] [Abstract][Full Text] [Related]
36. TPPP3 Associated with Prognosis and Immune Infiltrates in Head and Neck Squamous Carcinoma.
Yang Z; Li X; Li J; Su Q; Qiu Y; Zhang Z; Zhang L; Mo W
Biomed Res Int; 2020; 2020():3962146. PubMed ID: 33083464
[TBL] [Abstract][Full Text] [Related]
37. Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan-cancer.
Shen Y; Wei Z; Zhou C; Song J; Wang J; Wang J; Wu L; Fang S; Shen Z
J Clin Lab Anal; 2022 Sep; 36(9):e24600. PubMed ID: 35870182
[TBL] [Abstract][Full Text] [Related]
38. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
[TBL] [Abstract][Full Text] [Related]
39. Sterol regulatory element binding transcription factor 1 promotes proliferation and migration in head and neck squamous cell carcinoma.
Tan M; Lin X; Chen H; Ye W; Yi J; Li C; Liu J; Su J
PeerJ; 2023; 11():e15203. PubMed ID: 37090107
[TBL] [Abstract][Full Text] [Related]
40. Biomarker Potential of
Ju Y; Zhu F; Fang B
Int J Med Sci; 2024; 21(5):921-936. PubMed ID: 38617010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
